Prof. Dr. ID: 37856

Nicolaus-Martin Kröger

Head of Clinic

graph of relations

Publications

  1. 2009
  2. Second allogeneic stem cell transplantation in myeloid malignancies.

    Hartwig, M., Ocheni, S., Asenova, S., Wiedemann, B., Zabelina, T., Ayuketang Ayuk, F., Kabisch, H., Erttmann, R., Kröger, N., Zander, A. R. & Bacher, U., 2009, In: ACTA HAEMATOL-BASEL. 122, 4, p. 185-192 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  3. Second-generation tyrosine kinase inhibitors in the post-transplant period in patients with chronic myeloid leukemia or Philadelphia-positive acute lymphoblastic leukemia.

    Klyuchnikov, E., Schafhausen, P., Kröger, N., Brümmendorf, T., Osanmaz, O., Asenova, S., Zabelina, T., Ocheni, S., Ayuketang Ayuk, F., Zander, A. R. & Bacher, U., 2009, In: ACTA HAEMATOL-BASEL. 122, 1, p. 6-10 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  4. Sensitising leukemic cells by targeting microenvironment.

    Klyuchnikov, E. & Kröger, N., 2009, In: LEUKEMIA LYMPHOMA. 50, 3, p. 319-320 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  5. Severe aplastic anaemia following leflunomide therapy.

    Wüsthof, M., Smirnova, A., Bacher, U., Kröger, N., Zander, A. R., Schuch, G. & Bokemeyer, C., 2009, In: RHEUMATOLOGY.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  6. Successful unrelated donor stem cell transplantation for advanced myelofibrosis in an adult patient with history of orthotopic liver transplantation.

    Perz, J. B., Hegenbart, U., Kröger, N., Otto, G., Ho, A. D. & Dreger, P., 2009, In: HAEMATOLOGICA. 94, 4, p. 594-596 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  7. Syngenic graft-versus-chronic-myeloid-leukemia-effect?

    Ocheni, S., Schafhausen, P., Bacher, U., Fehse, B. & Kröger, N., 2009, In: CTT-Cell Ther Transpl. 1, 3, p. 66-68 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  8. The changing scene of allogeneic stem cell transplantation for chronic myeloid leukemia-a report from the German Registry covering the period from 1998 to 2004.

    Bacher, U., Klyuchnikov, E., Zabelina, T., Ottinger, H., Beelen, D., Schrezenmeier, H., Ehninger, G., Müller, C., Berger, J., Suttorp, M., Kolb, H-J., Kröger, N. & Zander, A. R., 2009, In: ANN HEMATOL.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  9. Unrelated donor stem cell transplantation in acquired severe aplastic anemia: a systematic review.

    Peinemann, F., Grouven, U., Kröger, N., Pittler, M., Zschorlich, B. & Lange, S., 2009, In: HAEMATOLOGICA. 94, 12, p. 1732-1742 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  10. 2008
  11. Anti-thymocyte globulin overcomes the negative impact of HLA mismatching in transplantation from unrelated donors.

    Ayuketang Ayuk, F., Diyachenko, G., Zabelina, T., Panse, J., Wolschke, C., Eiermann, T., Binder, T., Fehse, B., Erttmann, R., Kabisch, H., Bacher, U., Kröger, N. & Zander, A. R., 2008, In: EXP HEMATOL. 36, 8, p. 1047-1054 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  12. CD4+CD25+FOXP3+ T regulatory cells reconstitute and accumulate in the bone marrow of patients with multiple myeloma following allogeneic stem cell transplantation.

    Atanackovic, D., Cao, Y., Luetkens, T., Panse, J., Faltz, C., Arfsten, J., Bartels, K., Wolschke, C., Eiermann, T., Zander, A. R., Fehse, B., Bokemeyer, C. & Kröger, N., 2008, In: HAEMATOLOGICA. 93, 3, p. 423-430 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  13. Chemokine CXCL13 is overexpressed in the tumour tissue and in the peripheral blood of breast cancer patients.

    Panse, J., Friedrichs, K., Marx, A., Hildebrandt, Y., Luetkens, T., Barrels, K., Horn, C., Stahl, T., Cao, Y., Milde-Langosch, K., Niendorf, A., Kröger, N., Wenzel, S., Leuwer, R., Bokemeyer, C., Hegewisch-Becker, S. & Atanackovic, D., 2008, In: BRIT J CANCER. 99, 6, p. 930-938 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  14. Choosing between stem cell therapy and drugs in myelofibrosis.

    Kröger, N. & Mesa, R. A., 2008, In: LEUKEMIA. 22, 3, p. 474-486 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  15. Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation.

    Ayuketang Ayuk, F., Perez-Simon, J. A., Shimoni, A., Sureda, A., Zabelina, T., Schwerdtfeger, R., Martino, R., Sayer, H. G., Alegre, A., Lahuerta, J-J., Atanackovic, D., Wolschke, C., Nagler, A., Zander, A. R., Miguel, S., Kröger, N. & Kröger, N., 2008, In: HAEMATOLOGICA. 93, 9, p. 1343-1350 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  16. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.

    Ayuketang Ayuk, F., Diyachenko, G., Zabelina, T., Wolschke, C., Fehse, B., Bacher, U., Erttmann, R., Kröger, N. & Zander, A. R., 2008, In: BIOL BLOOD MARROW TR. 14, 8, p. 913-919 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  17. Complement-dependent and complement-independent cytotoxicity of polyclonal antithymocyte globulins in chronic lymphocytic leukemia.

    Ayuketang Ayuk, F., Atassi, N., Schuch, G., Mina, S., Fang, L., Bokemeyer, C., Fehse, B., Zander, A. R. & Kröger, N., 2008, In: LEUKEMIA RES. 32, 8, p. 1200-1206 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  18. Differences in proportion and dynamics of recipient hematopoiesis following hematopoietic cell transplantation in CML and IMF.

    Siebolts, U., Thiele, J., Zander, T., Ditschkowski, M., Beelen, D. W., Kröger, N., Fehse, B. & Wickenhauser, C., 2008, In: ONCOL REP. 19, 1, p. 287-292 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  19. EBV reactivation and post transplant lymphoproliferative disorders following allogeneic SCT.

    Ocheni, S., Kröger, N., Zabelina, T., Sobottka, I., Ayuketang Ayuk, F., Wolschke, C., Muth, A., Lellek, H., Petersen, L., Erttmann, R., Kabisch, H., Zander, A. R. & Bacher, U., 2008, In: BONE MARROW TRANSPL. 42, 3, p. 181-186 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  20. Epigenetic modulation and other options to improve outcome of stem cell transplantation in MDS.

    Kröger, N., 2008, In: HEMATOL-AM SOC HEMAT. p. 60-67

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  21. Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma.

    Schilling, G., Hansen, T., Shimoni, A., Zabelina, T., Pérez-Simón, J-A., Simon-Perez, J-A., Gutierrez, N. C., Fiedler, W., Liebisch, P., Schwerdtfeger, R., Bornhäuser, M., Otterstetter, S., Murga-Penas, E-M., Dierlamm, J., Ayuketang Ayuk, F., Atanackovic, D., Bacher, U., Bokemeyer, C., Zander, A. R., San Miguel, J., Miguel, J. S., Nagler, A. & Kröger, N., 2008, In: LEUKEMIA. 22, 6, p. 1250-1255 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  22. Minimal residual disease diagnostics in myeloid malignancies in the post transplant period.

    Bacher, U., Zander, A. R., Haferlach, T., Schnittger, S., Fehse, B. & Kröger, N., 2008, In: BONE MARROW TRANSPL. 42, 3, p. 145-157 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  23. Monitoring of minimal residual disease in multiple myeloma after allo-SCT: flow cytometry vs PCR-based techniques.

    Lioznov, M., Badbaran, A., Fehse, B., Bacher, U., Zander, A. R. & Kröger, N., 2008, In: BONE MARROW TRANSPL. 41, 10, p. 913-916 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  24. Randomized trial of high-dose adjuvant chemotherapy with autologous hematopoietic stem-cell support versus standard-dose chemotherapy in breast cancer patients with 10 or more positive lymph nodes: overall survival after 6 years of follow-up.

    Zander, A. R., Schmoor, C., Kröger, N., Krüger, W., Möbus, V., Frickhofen, N., Metzner, B., Berdel, W. E., Koenigsmann, M., Thiel, E., Wandt, H., Possinger, K., Kreienberg, R., Schumacher, M. & Jonat, W., 2008, In: ANN ONCOL. 19, 6, p. 1082-1089 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  25. Red blood cell transfusion dependence and outcome after allogeneic peripheral blood stem cell transplantation in patients with de novo myelodysplastic syndrome (MDS).

    Platzbecker, U., Bornhäuser, M., Germing, U., Stumpf, J., Scott, B. L., Kröger, N., Schwerdtfeger, R., Böhm, A., Kobbe, G., Theuser, C., Rabitsch, W., Valent, P., Sorror, M. L., Ehninger, G. & Deeg, H. J., 2008, In: BIOL BLOOD MARROW TR. 14, 11, p. 1217-1225 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  26. Relapse of postpolycythemia myelofibrosis after allogeneic stem cell transplantation in a polycythemic phase: successful treatment with donor lymphocyte infusion directed by quantitative PCR test for V617F-JAK2 mutation.

    Benjamini, O., Koren-Michowitz, M., Amariglio, N., Kröger, N., Nagler, A. & Shimoni, A., 2008, In: LEUKEMIA. 22, 10, p. 1961-1963 10.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  27. Safety of percutaneous dilational tracheostomy in hematopoietic stem cell transplantation recipients requiring long-term mechanical ventilation.

    Kluge, S., Baumann, H. J., Nierhaus, A., Kröger, N., Meyer, A. & Kreymann, K-G., 2008, In: J CRIT CARE. 23, 3, p. 394-398 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  28. Transportation and cryopreservation may impair haematopoietic stem cell function and engraftment of allogeneic PBSCs, but not BM.

    Lioznov, M., Dellbrügger, C., Sputtek, A., Fehse, B., Kröger, N. & Zander, A. R., 2008, In: BONE MARROW TRANSPL. 42, 2, p. 121-128 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  29. 2007
  30. Autologous stem cell transplantation in myelodysplastic syndromes.

    de Witte, T., Suciu, S., Brand, R., Muus, P. & Kröger, N., 2007, In: SEMIN HEMATOL. 44, 4, p. 274-277 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  31. Bortezomib in combination with intermediate-dose dexamethasone and continuous low-dose oral cyclophosphamide for relapsed multiple myeloma.

    Kropff, M., Bisping, G., Schuck, E., Liebisch, P., Lang, N., Hentrich, M., Dechow, T., Kröger, N., Salwender, H., Metzner, B., Sezer, O., Engelhardt, M., Wolf, H-H., Einsele, H., Volpert, S., Heinecke, A., Berdel, W. E. & Kienast, J., 2007, In: BRIT J HAEMATOL. 138, 3, p. 330-337 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  32. Dualism of mixed chimerism between hematopoiesis and stroma in chronic idiopathic myelofibrosis after allogeneic stem cell transplantation.

    Thiele, J., Varus, E., Siebolts, U., Kvasnicka, H. M., Wickenhauser, C., Metz, K. A., Beelen, D. W., Ditschkowski, M., Zander, A. R. & Kröger, N., 2007, In: HISTOL HISTOPATHOL. 22, 4, p. 365-372 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  33. Mini-Midi-Maxi? How to harness the graft-versus-myeloma effect and target molecular remission after allogeneic stem cell transplantation.

    Kröger, N., 2007, In: LEUKEMIA. 21, 9, p. 1851-1858 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  34. Monitoring of the JAK2-V617F mutation by highly sensitive quantitative real-time PCR after allogeneic stem cell transplantation in patients with myelofibrosis.

    Kröger, N., Badbaran, A., Holler, E., Hahn, J., Kobbe, G., Bornhäuser, M., Reiter, A., Zabelina, T., Zander, A. R. & Fehse, B., 2007, In: BLOOD. 109, 3, p. 1316-1321 3.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  35. Monitoring serum free light chains in patients with multiple myeloma who achieved negative immunofixation after allogeneic stem cell transplantation.

    Mösbauer, U., Ayuketang Ayuk, F., Schieder, H., Lioznov, M., Zander, A. R. & Kröger, N., 2007, In: HAEMATOLOGICA. 92, 2, p. 275-276 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  36. Peripheral blood or bone marrow cells in reduced-intensity or myeloablative conditioning allogeneic HLA identical sibling donor transplantation for multiple myeloma.

    Gahrton, G., Iacobelli, S., Bandini, G., Björkstrand, B., Corradini, P., Crawley, C., Hegenbart, U., Morgan, G., Kröger, N., Schattenberg, A., Schönland, S. O., Verdonck, L. F., Volin, L., de Witte, T. & Niederwieser, D., 2007, In: HAEMATOLOGICA. 92, 11, p. 1513-1518 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  37. Pharmacogenetic analysis of liver toxicity after busulfan/cyclophosphamide-based allogeneic hematopoietic stem cell transplantation.

    Goekkurt, E., Stoehlmacher, J., Stueber, C., Wolschke, C., Eiermann, T., Iacobelli, S., Zander, A. R., Ehninger, G. & Kröger, N., 2007, In: ANTICANCER RES. 27, 6, p. 4377-4380 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  38. Rapid regression of bone marrow fibrosis after dose-reduced allogeneic stem cell transplantation in patients with primary myelofibrosis.

    Kröger, N., Thiele, J., Zander, A. R., Schwerdtfeger, R., Kobbe, G., Bornhäuser, M., Bethge, W., Schubert, J., de Witte, T. & Kvasnicka, H. M., 2007, In: EXP HEMATOL. 35, 11, p. 1719-1722 11.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  39. 2006
  40. Allogeneic and syngeneic hematopoietic cell transplantation in patients with amyloid light-chain amyloidosis: a report from the European Group for Blood and Marrow Transplantation.

    Schönland, S. O., Lokhorst, H., Buzyn, A., Leblond, V., Hegenbart, U., Bandini, G., Campbell, A., Carreras, E., Ferrant, A., Grommisch, L., Jacobs, P., Kröger, N., Giorgio, L. N., Russell, N., Zachee, P., Goldschmidt, H., Iacobelli, S., Niederwieser, D. & Gahrton, G., 2006, In: BLOOD. 107, 6, p. 2578-2584 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  41. Allogeneic haematopoietic cell transplantation for chronic myelogenous leukaemia in the era of imatinib: a retrospective multicentre study.

    Bornhäuser, M., Kröger, N., Schwerdtfeger, R., Schafer-Eckart, K., Sayer, H. G., Scheid, C., Stelljes, M., Kienast, J., Mundhenk, P., Fruehauf, S., Kiehl, M. G., Wandt, H., Theuser, C., Ehninger, G. & Zander, A. R., 2006, In: EUR J HAEMATOL. 76, 1, p. 9-17 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  42. Allogeneic stem-cell transplantation in patients with refractory acute leukemia: a long-term follow-up.

    Oyekunle, A. A., Kröger, N., Zabelina, T., Ayuketang Ayuk, F., Schieder, H., Renges, H., Fehse, N., Waschke, O., Fehse, B., Kabisch, H. & Zander, A. R., 2006, In: BONE MARROW TRANSPL. 37, 1, p. 45-50 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  43. Autologous stem cell transplantation for therapy-related acute myeloid leukemia and myelodysplastic syndrome.

    Kröger, N., Brand, R., van Biezen, A., Cahn, J-Y., Slavin, S., Blaise, D., Sierra, J., Zander, A. R., Niederwieser, D. & de Witte, T., 2006, In: BONE MARROW TRANSPL. 37, 2, p. 183-189 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  44. Bortezomib after dose-reduced allogeneic stem cell transplantation for multiple myeloma to enhance or maintain remission status.

    Kröger, N., Zabelina, T., Ayuketang Ayuk, F., Atanackovic, D., Schieder, H., Renges, H. & Zander, A. R., 2006, In: EXP HEMATOL. 34, 6, p. 770-775 6.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  45. CD34(+)-selected stem cell boost for delayed or insufficient engraftment after allogeneic stem cell transplantation.

    Oyekunle, A., Koehl, U., Schieder, H., Ayuketang Ayuk, F., Renges, H., Fehse, N., Zabelina, T., Fehse, B., Klingebiel, T., Sputtek, A., Zander, A. R. & Kröger, N., 2006, In: CYTOTHERAPY. 8, 4, p. 375-380 4.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  46. Comparable results in patients with acute lymphoblastic leukemia after related and unrelated stem cell transplantation.

    Dahlke, J., Kröger, N., Zabelina, T., Ayuketang Ayuk, F., Wolschke, C., Renges, H-H., Krüger, W., Kruell, A., Hinke, A., Erttmann, R., Kabisch, H. & Zander, A. R., 2006, In: BONE MARROW TRANSPL. 37, 2, p. 155-163 2.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  47. Comparison of flow cytometry vs. a haematology cell analyser-based method to guide the optimal time-point for peripheral blood stem cell apheresis.

    Gutensohn, K., Magens, M., Krüger, W., Kröger, N. & Kühnl, P., 2006, In: VOX SANG. 90, 1, p. 53-58 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  48. Impact of the intensity of the pretransplantation conditioning regimen in patients with prior invasive aspergillosis undergoing allogeneic hematopoietic stem cell transplantation: A retrospective survey of the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation.

    Martino, R., Parody, R., Fukuda, T., Maertens, J., Theunissen, K., Ho, A., Mufti, G. J., Kröger, N., Zander, A. R., Heim, D., Paluszewska, M., Selleslag, D., Steinerova, K., Ljungman, P., Cesaro, S., Nihtinen, A., Cordonnier, C., Vazquez, L., López-Duarte, M., Lopez, J., Cabrera, R., Rovira, M., Neuburger, S., Cornely, O., Hunter, A. E., Marr, K. A., Dornbusch, H. J. & Einsele, H., 2006, In: BLOOD. 108, 9, p. 2928-2936 9.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  49. Kinetics of plasma-cell chimerism after allogeneic stem cell transplantation by highly sensitive real-time PCR based on sequence polymorphism and its value to quantify minimal residual disease in patients with multiple myeloma.

    Kröger, N., Zagrivnaja, M., Schwartz, S., Badbaran, A., Zabelina, T., Lioznov, M., Ayuketang Ayuk, F., Zander, A. R. & Fehse, B., 2006, In: EXP HEMATOL. 34, 5, p. 688-694 5.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  50. Low number of donor activating killer immunoglobulin-like receptors (KIR) genes but not KIR-ligand mismatch prevents relapse and improves disease-free survival in leukemia patients after in vivo T-cell depleted unrelated stem cell transplantation.

    Kröger, N., Binder, T., Zabelina, T., Wolschke, C., Schieder, H., Renges, H., Ayuketang Ayuk, F., Dahlke, J., Eiermann, T. & Zander, A. R., 2006, In: TRANSPLANTATION. 82, 8, p. 1024-1030 8.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  51. Oral valganciclovir leads to higher exposure to ganciclovir than intravenous ganciclovir in patients following allogeneic stem cell transplantation.

    Einsele, H., Reusser, P., Bornhäuser, M., Kalhs, P., Ehninger, G., Hebart, H., Chalandon, Y., Kröger, N., Hertenstein, B. & Rohde, F., 2006, In: BLOOD. 107, 7, p. 3002-3008 7.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  52. Prognostic and predictive effects of immunohistochemical factors in high-risk primary breast cancer patients.

    Kröger, N., Milde-Langosch, K., Riethdorf, S., Schmoor, C., Schumacher, M., Zander, A. R. & Löning, T., 2006, In: CLIN CANCER RES. 12, 1, p. 159-168 1.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  53. Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma.

    van de Donk, N. W. C. J., Kröger, N., Hegenbart, U., Corradini, P., San Miguel, J. F., Goldschmidt, H., Perez-Simon, J. A., Zijlmans, M., Raymakers, R. A., Montefusco, V., Ayuketang Ayuk, F., van Oers, M. H. J., Nagler, A., Verdonck, L. F. & Lokhorst, H. M., 2006, In: BONE MARROW TRANSPL. 37, 12, p. 1135-1141 12.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

  54. Randomized trial of single compared with tandem high-dose chemotherapy followed by autologous stem-cell transplantation in patients with chemotherapy-sensitive metastatic breast cancer.

    Kröger, N., Frick, M., Gluz, O., Mohrmann, S., Metzner, B., Jackisch, C., Ko, Y., Lindemann, H-W., Meier, C. R., Lohrmann, H. P., Ruffert, U., Hänel, M., Bodenstein, H., Neubauer, A., Ehninger, G., Wolf, H-H., Kolbe, K., Burock, K., Zander, A. R. & Nitz, U., 2006, In: J CLIN ONCOL. 24, 24, p. 3919-3926 24.

    Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review